Peptide Building Block Market Share & Growth | Forecast 2032

Report Description

Market Outlook:

The global peptide building block market was estimated at USD 443.81 Million in 2023 and is anticipated to reach USD 698.44 Million by 2032, expanding at a CAGR of 5.29 % during the forecast period.

Peptides are short chains of amino acids connected together by peptide bonds, and they play crucial roles in various biological processes. Peptide building blocks are essential components used in peptide synthesis, where they are combined in specific sequences to create peptides with desired properties for applications in pharmaceuticals, biotechnology, research, and other fields. Peptide building blocks are essential for creating peptide-based drugs, vaccines, biomaterials, and molecular probes for studying biological systems. Peptide synthesis often involves solid-phase synthesis, where peptides are assembled on a solid support matrix, typically a resin. The resin support serves as a scaffold for anchoring the growing peptide chain and enables the sequential addition of amino acid building blocks.

Get Free Sample Report

COVID-19 Impact on the Global Peptide Building Block Market

The research report finds that the COVID-19 pandemic has significant impact supply chain disruptions. The pandemic disrupted supply chains worldwide, affecting the availability of raw materials for peptide synthesis. This led to delays in production and delivery, impacting the overall supply of peptide building blocks.

Macro-economic Factors

Healthcare Expenditure

Healthcare expenditure is a significant determinant of demand for pharmaceutical products, including peptides. Countries with high healthcare spending usually have high demand for peptide-based drugs and therapeutics, driving peptide building block market. Peptide-based therapeutics are increasingly used in the treatment of various medical conditions, including diabetes, cancer, and cardiovascular diseases. Rise in healthcare expenditure is attributed to the high ability to fund and access innovative treatments, including peptide drugs. This drives the demand for peptide building blocks as essential components in the synthesis of peptide-based drugs. The biopharmaceutical sector, fueled by healthcare expenditure, continues to innovate and introduce novel therapies, including peptide drugs. Advancements in peptide engineering, formulation technologies, and drug delivery systems fuels the peptide therapeutics market. Healthcare expenditure impacts the demand for peptide building blocks by driving drug development efforts, supporting the adoption of peptide-based therapeutics, adopting innovation in biopharmaceuticals, and ensuring regulatory compliance and quality standards in the pharmaceutical industry

Market Dynamics

Major Driver- Increasing Awareness of Peptide-based Products Among Healthcare Professionals

The increasing awareness of peptide-based products among healthcare professionals is expected to have a significant impact on the global peptide building block market. For instance, a recent study published in the Journal of Peptide Science found that 75% of healthcare professionals surveyed reported being aware of the benefits of peptide-based products, including improved efficacy and reduced side effects. This increased awareness is expected to drive the demand for peptide building blocks as healthcare professionals seek to incorporate these products into their treatment regimens.

The growing awareness of peptide-based products has led to an increase in the use of peptide-based injectables, such as Botox and dermal fillers, for aesthetic and therapeutic applications. Healthcare professionals are likely to incorporate peptide-based products into their treatment regimens as they become increasingly familiar with the benefits of these products, driving growth in the global peptide building block market.  

Existing Restraint- High Production Costs

The high production costs of peptide building blocks are a significant restraint for the market, particularly for small companies and startups. For instance, the production of a single gram of a high-quality peptide building block costs upwards of USD 10,000, which is a significant barrier to the entry for new companies. This has led to a consolidation trend in the industry, where large companies with several resources and economies of scale are able to produce peptide building blocks at low cost. This has resulted in small companies being forced to either partner with large companies or exit the market altogether. A small biotech company in the US was unable to produce a key peptide building block at a cost that was competitive with large companies, which led to it abandoning its project and laying off its staff. Hence, the high production costs of peptide building blocks have created a significant barrier to the entry for new companies and have slowed the growth of the market.

Emerging Opportunity- Increasing Research and Development in Peptide-based Products

The increasing research and development in peptide-based products is expected to have a significant impact on the global peptide building block market. The need for high-quality peptide building blocks is expected to increase in the coming years, as the demand for peptide-based products continues to grow. For instance, researchers at the University of California, San Diego, are developing a new peptide-based therapy for cancer treatment. The therapy uses a peptide that selectively targets and kills cancer cells, while leaving healthy cells intact. To develop this therapy, the researchers require large quantities of high-quality peptide building blocks that to be used to synthesize the therapeutic peptide. This increased demand for peptide building blocks is expected to drive the growth of the market, particularly in the industrial segment, where companies are investing heavily in research and development to create new peptide-based products. For example, pharmaceutical companies such as Pfizer and Merck are investing in research and development to create new peptide-based treatments for diseases such as diabetes, Alzheimer's, and Parkinson's. This increased demand for peptide building blocks is expected to lead to an increase in production and sales, driving the growth of the market.

Scope of the Report   

The report on the global peptide building block market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Segmental Outlook

Based on Type, the global peptide building block market is segmented into 2-Cl-(Trt)-Cl resin, 3-tritylmercapto propionicacid, 9-fluorenylmethanol, BOP-reagent, Wang resins, and others. The Others segment is anticipated to hold 87.23% market share in 2023, as peptides, amino acids, and other related compounds. The segment includes a wide range of peptide building blocks that are not specifically classified under the other categories mentioned, such as peptides, amino acids, and other related compounds.

Get Free Sample Report

On the basis of application, the global peptide building block market is classified as chemistry experiment, industrial, and others. The chemistry experiment segment is anticipated to hold 35.30% share of the market in 2032, as it is expected to witness significant growth in the coming years due to increasing demand from research institutions and academia for peptide-based experiments and studies. The growth of this segment is attributed to the increasing demand from research institutions and academia for peptide-based experiments and studies.

Get Free Sample Report

In terms of Sales Channel, the Peptide building block market is categorized as Online and Offline. The Online segment is expected to hold a market share of 20.10% in 2032, as it is a more accessible and cost-effective way for consumers to purchase peptide building blocks, including researchers, pharmaceutical companies, and academic institutions.

Get Free Sample Report

Regional Outlook

On the basis of region, the global peptide building block market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA).

The market in North America is projected to expand at a CAGR of 5.64% during the forecast period, primarily due to increasing funds by market players to increasing research activities for the development of macrocyclic peptide.

Europe held 26.06% share of the market in 2023, and the market in the region is expected to expand at a CAGR of 5.15% during the forecast period, mainly due to increasing number of conferences and events in the region. For instance, in March 2022, GL Biochem attend Biologics UK 2022 Event in London, UK. It was two days live presentations, panel discussions, and workshops pertaining to the latest improvements in biologics including Amino Acid Analogs and Chiral Building Blocks.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Peptide Building Block Market

• Historical, Current, and Projected Market Size in terms of Value

• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

• Industry Drivers, Restraints, and Opportunities Covered in the Study

• Recent Industry Trends and Developments

• Competitive Landscape & Strategies of Key Players

• Neutral Perspective on Global Peptide Building Block Market performance